Yesintek 130 mg / 26 ml, Konzentrat zur Herstellung einer Infusionslösung

7680703290019 CH-70329 Konzentrat

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
01/07/2026
Summary of Product Characteristics
Français
01/07/2026
Summary of Product Characteristics
Italien
01/07/2026

Detailed composition

Substance Quantity Type Category
ustekinumabum
130.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
methioninum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.007 MMOL Substance HBESI

Reimbursement information

Public price
CHF 1252.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2026

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
70329
Drug name
Yesintek, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L04AC05
Authorization status
Z
Dispensing category
B
First authorization
10/02/2026
Authorization expiration date
09/02/2031
IT Number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn

Package details

Description (FR)
YESINTEK conc perf 130 mg/26ml flac
Description (DE)
YESINTEK Inf Konz 130 mg/26ml Durchstf
Market launch
01/07/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data